|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 10, 2018 ) Market Overview:
The Global Atopic Dermatitis treatment market is valued around USD 9.23 billion in 2018. It is predicted to grow at a CAGR of 13% to attain USD 17.01 billion by 2023. Atopic dermatitis, additionally known as eczema, is a situation in which skin turns into dry, itchy, and infected, which results in redness, swelling, scaling, and crusting. Atopic dermatitis is commonly observed in kids below one year. The precise reason of atopic dermatitis is undiscovered, but it is believed that it consists of genetics, environmental publicity, immune gadget dysfunction, and a problem with pores and skin permeability.
Request Report Sample: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/request-sample
Increasing prevalence of atopic dermatitis is to promote the growth of the market
Factors affecting market growth:
Technological advancements (+)
Climatic changes (+)
Increasing prevalence of atopic dermatitis (+)
Escalating growth in R&D (+)
Mounting focus on novel biologics (+)
Stringent government rules and regulations (-)
Allergic reactions of off-label therapies (-)
Get your customized report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/customize-report
Corticosteroids capture the most important market percentage
Market Segmentation
The Global Atopic Dermatitis treatment market is segmented on the basis of
Treatment Type
Introduction
Drug Treatment
Emollients
Antihistamines
Antibiotics
Corticosteroids
Calcineurin Inhibitors
Radiation Treatment
Route of administration
Introduction
Topical
Oral
Distribution Channel
Introduction
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Corticosteroids capture the most important market percentage and are predicted to retain their lead until the give up of 2022.
Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/
Key players:
The leading industries dominating the market include Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
